103 related articles for article (PubMed ID: 8835422)
1. Therapy of anemia in patients with multiple myeloma.
Adam Z; Krahulová M; Spelda S; Vorlícek J; Hejlová N; Hájek R; Tomíska M
Acta Med Austriaca; 1995; 22(4):59-64. PubMed ID: 8835422
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of treatment of anemia with erythropoietin in patients with multiple myeloma].
Adam Z; Krahulová M; Spelda S; Vorlícek J; Hejlová N; Hájek R; Tomíska M
Vnitr Lek; 1995 Nov; 41(11):767-72. PubMed ID: 8553596
[TBL] [Abstract][Full Text] [Related]
3. [Recombinant human erythropoietin in the treatment of anemia associated with lymphoproliferative diseases--chronic lymphadenosis and multiple myeloma].
Haber J; Spicka I; Petruzelka L; Kolesková E; Straub J; Jonásová A; Pospísilová B
Vnitr Lek; 1996 Apr; 42(4):262-7. PubMed ID: 8693713
[TBL] [Abstract][Full Text] [Related]
4. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
[TBL] [Abstract][Full Text] [Related]
5. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
[TBL] [Abstract][Full Text] [Related]
6. [Phase II clinical study of recombinant human erythropoietin on the anemia associated with multiple myeloma].
Urabe A; Mizoguchi H; Takaku F; Miyazaki T; Yachi A; Niitsu Y; Miura Y; Mutoh Y; Fujioka S; Nomura T
Rinsho Ketsueki; 1993 Aug; 34(8):919-27. PubMed ID: 8411646
[TBL] [Abstract][Full Text] [Related]
7. [Effect of treatment with recombinant erythropoietin in patients with multiple myeloma and kidney failure].
Spicka I; Svára F; Novosadová L; Mácel I; Válková V; Sulková S; Merta M; Klener P
Sb Lek; 1997; 98(2):127-33. PubMed ID: 9601805
[TBL] [Abstract][Full Text] [Related]
8. Daily subcutaneous administration of recombinant human erythropoietin (rhEPO) in peritoneal dialysis patients: a European dose-response study.
Faller B; Slingeneyer A; Waller M; Michel C; Grützmacher P; Müller HP; Barany P; Grabensee B; Issad B; Schmitt H
Clin Nephrol; 1993 Sep; 40(3):168-75. PubMed ID: 8403573
[TBL] [Abstract][Full Text] [Related]
9. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
[TBL] [Abstract][Full Text] [Related]
10. [Recombinant erythropoietin (r-HuEPO) in the treatment of anemia in multiple myeloma].
Spicka I; Haber J; Petruzelka L; Kolesková E; Sálková J; Straub J; Zounar R; Klener P
Cas Lek Cesk; 1996 Jul; 135(14):450-3. PubMed ID: 8925545
[TBL] [Abstract][Full Text] [Related]
11. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
Voravud N; Sriuranpong V
J Med Assoc Thai; 2005 May; 88(5):607-12. PubMed ID: 16149676
[TBL] [Abstract][Full Text] [Related]
12. [Successful treatment of anemia in hemolysis patients using recombinant human erythropoietin. Maintenance dosage and serum concentration].
Stutz B; Rhyner K; Vögtli J; Binswanger U
Schweiz Med Wochenschr; 1987 Sep; 117(38):1397-402. PubMed ID: 3672079
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of erythropoietin in anemia of patients with immuno-lymphoproliferative disease].
Longo G; Fiorani C; Bonacorsi G; Vanzanelli P; Sani F; Bevini M; Curci G; Torelli U
Recenti Prog Med; 1992; 83(7-8):449-54. PubMed ID: 1529159
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin treatment of anemia associated with multiple myeloma.
Ludwig H; Fritz E; Kotzmann H; Höcker P; Gisslinger H; Barnas U
N Engl J Med; 1990 Jun; 322(24):1693-9. PubMed ID: 2342535
[TBL] [Abstract][Full Text] [Related]
15. [High-dose induction therapy followed by maintenance with recombinant human erythropoietin for 30 patients with tumor-related anemia].
Xu F; Zhang L; Xiang XJ; Wang ZQ; Zhou ZM; Wang SY
Ai Zheng; 2006 Sep; 25(9):1120-2. PubMed ID: 16965653
[TBL] [Abstract][Full Text] [Related]
16. [The role of iron deficiency on the development of anemia in patients on regular dialysis therapy].
Zadrazil J; Papajík T; Bachleda P; Budíková M; Novotný D; Scudla V
Vnitr Lek; 1994 Jun; 40(6):362-6. PubMed ID: 8073646
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of anemia in hemodialysis patients using recombinant human erythropoietin: advantages and disadvantages].
Zehnder C; Blumberg A
Schweiz Med Wochenschr; 1989 Mar; 119(9):269-75. PubMed ID: 2711161
[TBL] [Abstract][Full Text] [Related]
18. Use of erythropoietin in patients with multiple myeloma.
Egerer G; Harter C; Karthaus M; Ho AD; Goldschmidt H
Onkologie; 2003 Feb; 26(1):80-4. PubMed ID: 12624523
[TBL] [Abstract][Full Text] [Related]
19. Treatment of the anemia of multiple myeloma: the role of recombinant human erythropoietin.
Barlogie B
Semin Hematol; 1993 Oct; 30(4 Suppl 6):25-7. PubMed ID: 8153675
[TBL] [Abstract][Full Text] [Related]
20. [Guidelines for the treatment of anemia in chronic renal failure].
Triolo G;
G Ital Nefrol; 2003; 20 Suppl 24():S61-82. PubMed ID: 14666504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
